Universal Technical Institute Inc: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Aug 7, 2025 and accepted by EDGAR at Aug 7, 2025, 08:35 ET.
Management's discussion and analysis
As filed, 53,572 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our 2024 Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Risk Factors” in our 2024 Annual Report on Form 10-K and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also “Cautionary Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.
Company Overview
Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs.
Universal Technical Institute (“UTI”): UTI operates 15 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs. UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.
Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, certificate and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs as “Concorde Career College” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.
“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on our segments.
All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended, commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education (“ED”). Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs and under the Workforce Innovation and Opportunity Act.
We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.
Overview of the Three and Nine Months Ended June 30, 2025
Student Metrics
| UTI | Three Months Ended June 30,% 2025 | 2024 | Change | Nine Months Ended June 30,% 2025 | 2024 | Change |
|---|---|---|---|---|---|---|
| Total new student starts | 2,829 | 2,916 | (3.0)% | 9,173 | 8,070 | 13.7% |
| Average full-time active students | 14,205 | 13,041 | 8.9% | 14,815 | 13,724 | 7.9% |
| End of period full-time active students | 13,874 | 12,686 | 9.4% | 13,874 | 12,686 | 9.4% |
| Concorde | ||||||
| Total new student starts | 2,892 | 2,651 | 9.1% | 8,511 | 7,323 | 16.2% |
| Average full-time active students | 9,552 | 8,038 | 18.8% | 9,659 | 8,263 | 16.9% |
| End of period full-time active students | 8,495 | 7,442 | 14.1% | 8,495 | 7,442 | 14.1% |
| Consolidated | ||||||
| Total new student starts | 5,721 | 5,567 | 2.8% | 17,684 | 15,393 | 14.9% |
| Average full-time active students | 23,757 | 21,079 | 12.7% | 24,474 | 21,987 | 11.3% |
| End of period full-time active students | 22,369 | 20,128 | 11.1% | 22,369 | 20,128 | 11.1% |
For the three and nine months ended June 30, 2025, the increase in consolidated new student starts, average full-time active students and end of period full-time active students was primarily due to new program rollouts and increased student demand for existing programs across both segments as compared to the prior year. The UTI segment benefited from the successful launch of three new programs launched in the second half of fiscal 2024 and nine new programs in fiscal 2025. In the Concorde segment, increases to our student population during the three and nine months ended June 30, 2025 were primarily driven by the successful launch of five new programs at three campuses during fiscal 2024, and the introduction of new cash pay “short programs” at a number of campuses.
Our ability to start new students can be influenced by various factors including: the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education; unemployment rates; competition; adverse media coverage, legislative, or regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate “for-profit” education industry in a negative light; and pandemics and or other national, state or local emergencies as declared by various government authorities.
Operations
Revenues for the three months ended June 30, 2025 were $204.3 million, an increase of $26.8 million, or 15.1%, from the comparable period in the prior year. UTI revenues increased by approximately $14.3 million, or 12.2%, and Concorde revenues increased by approximately $12.5 million, or 20.7%. Both segment increases were primarily driven by the higher average full-time active students.
Revenues for the nine months ended June 30, 2025 were $613.2 million, an increase of $76.8 million, or 14.3%, from the comparable period in the prior year. UTI revenues increased by approximately $41.3 million, or 11.6%, and Concorde revenues increased by approximately $35.5 million, or 19.7%. Both segment increases were primarily driven by the higher average full-time active students.
Total income from operations was $14.2 million and $58.5 million during the three and nine months ended June 30, 2025, compared to $7.4 million and $32.9 million for the three and nine months ended June 30, 2024. The increase for the three and nine months ended June 30, 2025 was primarily driven by the increased revenues from the larger student population. Additionally, productivity improvements and proactive cost reductions have been a key part of our operating model for the past several years, and we continue to identify and execute on optimization opportunities throughout our operations in both segments.
Business Strategy
Our business strategy, internally known as our “North Star strategy,” has three core tenets: (i) to grow the business by more deeply penetrating existing target markets and adding new markets; (ii) to diversify the business by adding new locations, programs, and offerings that maximize the lifetime value of our students; and (iii) to continually optimize the business by constantly enhancing operational efficiency.
During the nine months ended June 30, 2025, we executed the following as part of our business strategy:
- UTI announced Atlanta, Georgia as the location of the division’s next new campus (“UTI Atlanta”), continuing the company's execution of its North Star strategy. Pending regulatory approvals, UTI Atlanta will open in 2026.
- UTI announced the division’s second new campus will be in San Antonio, Texas (“UTI San Antonio”). This new campus, once open, will be the first skilled trades and energy education focused campus. Similar to above, pending regulatory approvals, UTI San Antonio will open in 2026, bringing the total number of UTI campuses nationwide to 17.
- Concorde signed a new facility lease agreement related to our partnership with Heartland Dental to construct a new co-branded campus in Fort Myers, Florida, which is expected to open in early fiscal 2026, pending regulatory approvals, and will bring the total number of Concorde campuses nationwide to 18. Construction began during the second quarter of 2025.
- UTI has announced the expansion of its successful Manufacturer Specific Advanced Training program by adding Tesla's START Collision Repair program. Tesla's START program is an intensive training program that prepares workers for successful careers at Tesla and began at the Long Beach, California campus in the third quarter of 2025.
- UTI launched its HVACR program at the Sacramento, California and Orlando, Florida campuses in March 2025. The program covers topics such as air handling, AC and DC circuits, sheet metal ductwork, and troubleshooting. This program is now offered at UTI campuses in seven states.
- UTI announced the expansion of its core automotive program to include new Battery Hybrid Electric Vehicle and Electric Vehicle (“EV”) courses with roll out completed during the first quarter of 2025 at the Avondale, Arizona and Orlando, Florida campuses. Rollouts were completed during the second quarter of 2025 at the following campuses: Bloomfield, New Jersey; Dallas, Texas; Austin, Texas; and Houston, Texas. In addition, during the third quarter of 2025, the program launched at the Miramar, Florida campus. This expansion builds on existing EV training at UTI's California campuses and covers topics such as high-voltage vehicle operation, electric vehicle components, diagnosis, and service.
- UTI announced a new partnership with FirstCall Mechanical, a leading provider of HVACR services to commercial and industrial sectors, as part of its early employment program. As part of this partnership, students in the HVACR program at Mooresville, North Carolina, Orlando, Florida, and Austin, Texas can apply for roles at FirstCall Mechanical and start working while still in school.
- UTI partnered with Loftin Equipment Company through its early employment program. Across three campuses in Texas and one campus in Arizona, this program offers diesel technology students the opportunity to gain paid work experience while completing their education. Students enrolled in the industrial maintenance program in one campus in Texas are also eligible for this opportunity.
In addition, we continue to pursue other opportunities that align with our business strategy.
Regulatory Environment
See Note 18 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.
Results of Operations: Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024
The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.
| Three Months Ended June 30, 2025 | 2024 | |
|---|---|---|
| Revenues | 100.0% | 100.0% |
| Operating expenses: | ||
| Educational services and facilities | 51.7% | 53.7% |
| Selling, general and administrative | 41.4% | 42.1% |
| Total operating expenses | 93.1% | 95.8% |
| Income from operations | 6.9% | 4.2% |
| Interest income | 0.7% | 0.8% |
| Interest expense | (0.7)% | (1.2)% |
| Other income (expense), net | 0.1% | —% |
| Total other income (expense), net | 0.1% | (0.4)% |
| Income before income taxes | 7.0% | 3.8% |
| Income tax expense | (1.8)% | (1.0)% |
| Net income | 5.2% | 2.8% |
Revenues
The following table presents revenue by segment (in thousands):
| Three Months Ended June 30, 2025 UTI | Concorde | Consolidated | Three Months Ended June 30, 2024 UTI | Concorde | Consolidated | |
|---|---|---|---|---|---|---|
| Revenue | $131,463 | $72,835 | $204,298 | $117,134 | $60,324 | $177,458 |
| Year over Year % Change | 12.2% | 20.7% | 15.1% |
Revenues for the three months ended June 30, 2025 were $204.3 million, an increase of $26.8 million, or 15.1%, as compared to revenues of $177.5 million for the three months ended June 30, 2024.
UTI
Revenues for UTI for the three months ended June 30, 2025 were $131.5 million compared to $117.1 million in the prior period. Revenue increased primarily due to an 8.9% increase in average full-time active students from the prior period.
Concorde
Revenues for Concorde for the three months ended June 30, 2025 were $72.8 million compared to $60.3 million in the prior period. Revenues increased primarily due to an 18.8% increase in average full-time active students from the prior period.
Educational services and facilities expenses
Educational services and facilities expenses were $105.6 million for the three months ended June 30, 2025, as compared to $95.3 million for the three months ended June 30, 2024. This increase was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.
The following tables set forth the significant components of our educational services and facilities expenses by segment (in thousands):
| Three Months Ended June 30, 2025 UTI | Concorde | Consolidated | |
|---|---|---|---|
| Salaries, employee benefits and tax expense | $32,881 | $27,631 | $60,512 |
| Bonus expense | 934 | 755 | 1,689 |
| Stock-based compensation | 137 | — | 137 |
| Compensation and related costs | 33,952 | 28,386 | 62,338 |
| Occupancy costs | 8,413 | 5,986 | 14,399 |
| Supplies, maintenance and student expense | 6,150 | 4,583 | 10,733 |
| Depreciation and amortization expense | 6,035 | 1,679 | 7,714 |
| Contract services expense | 994 | 583 | 1,577 |
| Other educational services and facilities expense | 5,545 | 3,298 | 8,843 |
| Total educational services and facilities expense | $61,089 | $44,515 | $105,604 |
| Three Months Ended June 30, 2024 UTI | Concorde | Consolidated | |
|---|---|---|---|
| Salaries, employee benefits and tax expense | $30,139 | $23,360 | $53,499 |
| Bonus expense | 867 | 293 | 1,160 |
| Stock-based compensation | 109 | — | 109 |
| Compensation and related costs | 31,115 | 23,653 | 54,768 |
| Occupancy costs | 7,558 | 5,544 | 13,102 |
| Supplies, maintenance and student expense | 7,206 | 4,075 | 11,281 |
| Depreciation and amortization expense | 5,651 | 1,167 | 6,818 |
| Contract services expense | 698 | 501 | 1,199 |
| Other educational services and facilities expense | 5,297 | 2,812 | 8,109 |
| Total educational services and facilities expense | $57,525 | $37,752 | $95,277 |
UTI
Compensation and related costs increased by $2.8 million for the three months ended June 30, 2025, primarily due to instructors and other campus related personnel hired to support the new programs and overall growth in the student population.
Occupancy costs increased by $0.9 million for the three months ended June 30, 2025, primarily due to new lease activity associated with the announced new campus growth and annual rate increases on existing leases.
Supplies, maintenance and student expense decreased by $1.1 million for the three months ended June 30, 2025, primarily due to a decrease of $0.7 million in student housing expenses.
Concorde
Compensation and related costs increased by $4.7 million for the three months ended June 30, 2025, primarily due to instructors and other campus related personnel hired to support overall student growth and the launch of additional programs.
Depreciation and amortization expense increased by $0.5 million during the three months ended June 30, 2025, primarily due to new capital expenditures and program expansions to accommodate a higher volume of students.
Other educational services and facilities expense increased by $0.5 million during the three months ended June 30, 2025, primarily due to higher expenses for training aids and insurance.
Selling, general and administrative expenses
Selling, general and administrative expenses for the three months ended June 30, 2025 were $84.5 million, as compared to $74.7 million for the three months ended June 30, 2024. This increase was primarily due to costs associated with our business strategies.
The following tables set forth the significant components of our selling, general and administrative expenses by segment (in thousands):
| Three Months Ended June 30, 2025 UTI | Concorde | Corporate | Consolidated | |
|---|---|---|---|---|
| Salaries, employee benefits and tax expense | $20,457 | $7,142 | $6,337 | $33,936 |
| Bonus expense | 2,044 | 426 | 1,510 | 3,980 |
| Stock-based compensation | 393 | 208 | 1,920 | 2,521 |
| Compensation and related costs | 22,894 | 7,776 | 9,767 | 40,437 |
| Advertising and marketing expense | 15,010 | 7,534 | 151 | 22,695 |
| Professional and contract services expense | 2,093 | 668 | 3,819 | 6,580 |
| Other selling, general and administrative expenses | 10,507 | 6,413 | (2,090) | 14,830 |
| Total selling, general and administrative expenses | $50,504 | $22,391 | $11,647 | $84,542 |
| Three Months Ended June 30, 2024 UTI | Concorde | Corporate | Consolidated | |
|---|---|---|---|---|
| Salaries, employee benefits and tax expense | $20,010 | $7,066 | $4,045 | $31,121 |
| Bonus expense | 3,248 | 807 | 2,467 | 6,522 |
| Stock-based compensation | 409 | 56 | 1,289 | 1,754 |
| Compensation and related costs | 23,667 | 7,929 | 7,801 | 39,397 |
| Advertising and marketing expense | 13,169 | 6,067 | 186 | 19,422 |
| Professional and contract services expense | 1,760 | 1,850 | 3,054 | 6,664 |
| Other selling, general and administrative expenses | 6,877 | 3,010 | (635) | 9,252 |
| Total selling, general and administrative expenses | $45,473 | $18,856 | $10,406 | $74,735 |
UTI
Compensation and related costs decreased by $0.8 million for the three months ended June 30, 2025 primarily due to lower bonus expense when compared to the prior year.
Advertising and marketing expense increased year over year by $1.8 million. UTI advertising and marketing expense as a percentage of revenues increased to 11.4% for the three months ended June 30, 2025 as compared to 11.2% in the prior year.
Other selling, general and administrative expenses increased by $3.6 million primarily due to a $2.2 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $1.6 million over the prior year as a result of higher revenues and student volumes.
Concorde
Advertising and marketing increased year over year by $1.5 million. Concorde advertising and marketing expense as a percentage of revenues for the three months ended June 30, 2025 and 2024 was 10.3% and 10.1%, respectively.
Professional and contract services expense decreased by $1.2 million for the three months ended June 30, 2025 primarily due to a reduction of legal and contract service expenses as several of the integration activities were completed in the prior year.
Other selling, general and administrative expenses increased by $3.4 million for the three months ended June 30, 2025 primarily related to an increase in the provision for credit losses of $2.4 million, an increase in software expenses of $0.4 million, and a $0.3 million increase in human resource expenses. These increases are aligned with higher revenues and higher capital expenditures to support our larger student and employee volumes.
Corporate
Compensation and related costs increased by $2.0 million three months ended June 30, 2025 primarily due to additional headcount hired to support the execution of our business strategies.
Professional fees and contract services increased by $0.8 million for the three months ended June 30, 2025 primarily due to an increase of $0.4 million for legal expenses and other projects to support our business strategies.
Other selling, general and administrative expenses decreased by $1.5 million for the three months ended June 30, 2025. This decrease is primarily due to an increase of $2.5 million in corporate expenses that were allocated to the UTI and Concorde segments compared to the prior period. These corporate expenses included primarily human resource expenses and information technology costs that increased with the overall headcount and operations. The decrease in expenses is partially offset by a $0.7 million increase in software expenses and a $0.3 million increase in employee awards.
Income taxes
Income tax expense for the three months ended June 30, 2025 was $3.7 million, or 25.7% of pre-tax income, compared to $1.8 million, or 26.2% of pre-tax income, for the three months ended June 30, 2024. The effective income tax rate for the three months ended June 30, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three months ended June 30, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.
Results of Operations: Nine Months Ended June 30, 2025 Compared to Nine Months Ended June 30, 2024
The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.
| Nine Months Ended June 30, 2025 | 2024 | |
|---|---|---|
| Revenues | 100.0% | 100.0% |
| Operating expenses: | ||
| Educational services and facilities | 50.3% | 53.2% |
| Selling, general and administrative | 40.2% | 40.7% |
| Total operating expenses | 90.5% | 93.9% |
| Income from operations | 9.5% | 6.1% |
| Interest income | 0.9% | 0.9% |
| Interest expense | (0.8)% | (1.3)% |
| Other income (expense), net | —% | 0.1% |
| Total other income (expense), net | 0.1% | (0.3)% |
| Income before income taxes | 9.6% | 5.8% |
| Income tax expense | (2.4)% | (1.4)% |
| Net income | 7.2% | 4.3% |
| Preferred stock dividends | —% | (0.2)% |
| Income available for distribution | 7.2% | 4.1% |
| Income allocated to participating securities | —% | (0.5)% |
| Net income available to common shareholders | 7.2% | 3.6% |
29
Revenues
The following table presents revenue by segment (in thousands):
| Nine Months Ended June 30, 2025 UTI | Concorde | Consolidated | Nine Months Ended June 30, 2024 UTI | Concorde | Consolidated | |
|---|---|---|---|---|---|---|
| Revenue | $397,169 | $216,005 | $613,174 | $355,831 | $180,498 | $536,329 |
| Year over Year % Change | 11.6% | 19.7% | 14.3% |
Revenues for the nine months ended June 30, 2025 were $613.2 million, an increase of $76.8 million, or 14.3%, as compared to revenues of $536.3 million for the nine months ended June 30, 2024.
UTI
Revenues for UTI for the nine months ended June 30, 2025 were $397.2 million compared to $355.8 million in the prior year period. Revenue increased primarily due to a 13.7% increase in new student starts and a 7.9% increase in average full-time active students from the prior period.
Concorde
Revenues for Concorde for the nine months ended June 30, 2025 were $216.0 million compared to $180.5 million in the prior year period. Revenues increased primarily due to an 16.2% increase in new student starts and a 16.9% increase in average full-time active students from the prior period.
Educational services and facilities expenses
Educational services and facilities expenses were $308.2 million for the nine months ended June 30, 2025, as compared to $285.2 million for the nine months ended June 30, 2024, which was primarily due to the increased student volumes during the period and costs associated with execution of our business strategies, partially offset by cost savings from our operational initiatives.
The following table sets forth the significant components of our educational services and facilities expenses by segment (in thousands):
| Nine Months Ended June 30, 2025 UTI | Concorde | Consolidated | |
|---|---|---|---|
| Salaries, employee benefit and tax expenses | $96,579 | $80,018 | $176,597 |
| Bonus expense | 2,411 | 1,798 | 4,209 |
| Stock-based compensation | 341 | — | 341 |
| Compensation and related costs | 99,331 | 81,816 | 181,147 |
| Occupancy costs | 23,805 | 16,819 | 40,624 |
| Supplies and maintenance and student expense | 20,313 | 12,624 | 32,937 |
| Depreciation and amortization expense | 17,913 | 4,729 | 22,642 |
| Contract services expense | 3,028 | 1,764 | 4,792 |
| Other educational services and facilities expense | 17,287 | 8,804 | 26,091 |
| Total educational services and facilities expense | $181,677 | $126,556 | $308,233 |
30
| Nine Months Ended June 30, 2024 UTI | Concorde | Consolidated | |
|---|---|---|---|
| Salaries, employee benefit and tax expenses | $87,697 | $68,954 | $156,651 |
| Bonus expense | 2,266 | 763 | 3,029 |
| Stock-based compensation | 300 | — | 300 |
| Compensation and related costs | 90,263 | 69,717 | 159,980 |
| Occupancy costs | 22,602 | 16,531 | 39,133 |
| Supplies, maintenance and student expense | 25,721 | 12,287 | 38,008 |
| Depreciation and amortization expense | 16,628 | 3,179 | 19,807 |
| Contract services expense | 2,733 | 1,530 | 4,263 |
| Other educational services and facilities expense | 17,046 | 6,937 | 23,983 |
| Total educational services and facilities expense | $174,993 | $110,181 | $285,174 |
UTI
Compensation and related costs increased by $9.1 million for the nine months ended June 30, 2025 primarily due to additional instructors and other campus related personnel hired to support the new programs added and overall growth in the student population.
Occupancy costs increased by $1.2 million for the nine months ended June 30, 2025, primarily due to new lease activity associated with the announced new campus growth and annual rate increases on existing leases.
Supplies, maintenance and student expense decreased by $5.4 million for the nine months ended June 30, 2025 primarily due to a $5.2 million decrease in student housing expenses.
Depreciation and amortization expense increased by $1.3 million for the nine months ended June 30, 2025 primarily due to increased capital expenditures related to the new program launches and expansions.
Concorde
Compensation and related costs increased by $12.1 million for the nine months ended June 30, 2025 primarily due to increased instructors and other campus related personnel hired to support overall growth in the student population and new program expansions.
Depreciation and amortization expense increased by $1.6 million during the nine months ended June 30, 2025, primarily due to new capital expenditures and program expansions to accommodate a higher volume of students.
Other educational services and facilities expense increased by $1.9 million during the nine months ended June 30, 2025, primarily due to higher expenses for training aids and insurance.
Selling, general and administrative expenses
Selling, general and administrative expenses for the nine months ended June 30, 2025 were $246.5 million. This represents an increase of $28.2 million, as compared to $218.3 million for the nine months ended June 30, 2024, which is primarily due to costs associated with our business strategies.
The following table sets forth the significant components of our selling, general and administrative expenses by segment (in thousands):
| Nine Months Ended June 30, 2025 UTI | Concorde | Corporate | Consolidated | |
|---|---|---|---|---|
| Salaries, employee benefit and tax expense | $61,183 | $20,026 | $17,378 | $98,587 |
| Bonus expense | 8,176 | 1,579 | 5,277 | 15,032 |
| Stock-based compensation | 1,138 | 476 | 4,447 | 6,061 |
| Compensation and related costs | 70,497 | 22,081 | 27,102 | 119,680 |
| Advertising and marketing expense | 44,536 | 22,791 | 551 | 67,878 |
| Professional and Contract services expense | 5,876 | 2,152 | 11,672 | 19,700 |
| Other selling, general and administrative expenses | 27,821 | 16,419 | (5,040) | 39,200 |
| Total selling, general and administrative expenses | $148,730 | $63,443 | $34,285 | $246,458 |
| Nine Months Ended June 30, 2024 UTI | Concorde | Corporate | Consolidated | |
|---|---|---|---|---|
| Salaries, employee benefit and tax expense | $58,581 | $20,605 | $11,469 | $90,655 |
| Bonus expense | 8,766 | 2,023 | 4,617 | 15,406 |
| Stock-based compensation | 1,001 | 133 | 4,265 | 5,399 |
| Compensation and related costs | 68,348 | 22,761 | 20,351 | 111,460 |
| Advertising and marketing expense | 40,422 | 19,199 | 397 | 60,018 |
| Professional and Contract services expense | 5,083 | 5,449 | 8,575 | 19,107 |
| Other selling, general and administrative expenses | 19,673 | 8,818 | (790) | 27,701 |
| Total selling, general and administrative expenses | $133,526 | $56,227 | $28,533 | $218,286 |
UTI
Compensation and related costs increased by $2.1 million for the nine months ended June 30, 2025 primarily due to an increase in headcount to support the new campus and program growth for the UTI segment.
Advertising and marketing expense increased by $4.1 million for the nine months ended June 30, 2025. Advertising and marketing expense as a percentage of revenues decreased to 11.2% for the nine months ended June 30, 2025 as compared to 11.4% in the prior year.
Professional and contract services expenses increased by $0.8 million for the nine months ended June 30, 2025 primarily due to projects to support the new campus and program growth for the UTI segment.
Other selling, general and administrative expenses increased by $8.1 million for the nine months ended June 30, 2025 primarily due to a $5.4 million increase in allocated corporate expenses related to human resources and information technology due to growth in headcount to support the UTI segment and our business strategies. Additionally, the provision for credit losses increased by $2.4 million over the prior year as a result of higher revenue and student volumes.
Concorde
Concorde compensation and related costs decreased by $0.7 million for the nine months ended June 30, 2025 primarily due to continued integration activities and the centralization of more processes within the Corporate division.
Advertising and marketing expense increased by $3.6 million for the nine months ended June 30, 2025. Advertising and marketing expense as a percentage of revenues was 10.6% for both the nine months ended June 30, 2025 and 2024.
Professional and contract services expense decreased by $3.3 million for the nine months ended June 30, 2025 primarily due a decrease of $1.7 million in legal fees and a decrease of $1.6 million in contract services as several of the integration activities were completed in the prior year.
Other selling, general and administrative expense increased by $7.6 million for the nine months ended June 30, 2025 primarily related to an increase in the provision for credit losses of $5.2 million, an increase in software expenses of $1.2 million, and an increase in allocated corporate expenses related to human resources and information technology expenses of $0.7 million. These increases are aligned with our higher revenues and to support our larger student and employee volumes.
Corporate
Corporate compensation and related costs increased by $6.8 million for the nine months ended June 30, 2025 primarily due to additional headcount hired to support the execution of our business strategies.
Professional and contract services expense increased by $3.1 million for the nine months ended June 30, 2025 primarily due to an increase of $1.7 million for legal expenses and a $1.3 million increase related to professional and contract services for projects that support our business strategies.
Other selling, general and administrative expenses decreased by $4.3 million for the nine months ended June 30, 2025. This decrease is primarily due to an increase of $6.1 million in corporate expenses that were allocated to the UTI and Concorde segments compared to the prior period. These corporate expenses included primarily human resource expenses and information technology expenses that increased with the overall headcount and operations. This decrease is partially offset by a $1.1 million increase in software expenses and a $1.1 million increase in employee-related costs primarily driven by recruitment efforts.
Income taxes
Our income tax expense for the nine months ended June 30, 2025 was $14.5 million, or 24.6% of pre-tax income, compared to $7.7 million, or 24.9% of pre-tax income, for the nine months ended June 30, 2024. The effective income tax rate for the nine months ended June 30, 2025 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, stock-based compensation expense, refinements to the federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the nine months ended June 30, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details.
Preferred stock dividends
As of December 18, 2023, no shares of the Series A Preferred Stock remained outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.
Pursuant to the Certificate of Designations, we recorded a preferred stock cash dividend of $1.1 million prior to the Series A preferred conversion during the nine months ended June 30, 2024.
Income available for distribution
Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $44.3 million and $22.1 million for the nine months ended June 30, 2025 and 2024, respectively.
Income allocated to participating securities
Our previously outstanding Series A Preferred Stock was considered a participating security because, in the event that we paid a dividend or made a distribution on the outstanding common stock, we were required to pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.
As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. There was no income allocated to participating securities for the nine months ended June 30, 2025. The amount of income allocated to the participating securities for the nine months ended June 30, 2024 was $2.9 million.
Net income available to common shareholders
After allocating the income to the participating securities, we had $44.3 million and $19.2 million of net income available to common shareholders for the nine months ended June 30, 2025 and 2024, respectively.
Non-GAAP Financial Measures
Our earnings before interest, income taxes, depreciation and amortization (“EBITDA”) for the three and nine months ended June 30, 2025 were $22.6 million and $83.1 million, respectively, compared to $14.8 million and $54.8 million for the three and nine months ended June 30, 2024. We define EBITDA as net income (loss), before interest (income) expense, income tax expense (benefit), and depreciation and amortization.
EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
EBITDA reconciles to net income, as follows (in thousands):
| Three Months Ended June 30, 2025 | 2024 | Nine Months Ended June 30, 2025 | 2024 | |
|---|---|---|---|---|
| Net income | $10,663 | $4,985 | $44,262 | $23,161 |
| Interest income | (1,445) | (1,440) | (4,833) | (4,842) |
| Interest expense | 1,394 | 2,149 | 4,724 | 7,204 |
| Income tax expense | 3,689 | 1,772 | 14,453 | 7,699 |
| Depreciation and amortization | 8,315 | 7,376 | 24,452 | 21,562 |
| EBITDA | $22,616 | $14,842 | $83,058 | $54,784 |
Liquidity and Capital Resources
Overview of Liquidity
Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand, short-term investments, and the Revolving Credit Facility will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced growth, diversification and optimization initiatives throughout the fiscal year and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation and expansion of new programs in existing markets where we continue to optimize utilization of our campus facilities.
Our aggregate cash and cash equivalents were $70.7 million as of June 30, 2025, a decrease of $91.2 million from September 30, 2024 due primarily to cash used to purchase held-to-maturity investments of $54.6 million, and net repayments of $50.0 million to the Revolving Credit Facility. Our available liquidity under the Revolving Credit Facility was $119.0 million as of June 30, 2025.
Strategic Uses of Cash
We believe that uses of our cash resources may include consideration of additional strategic acquisitions and organic growth initiatives, the purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, and cash and cash equivalents, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.
Long-term Debt and Letters of Credit
As of June 30, 2025, we had $74.1 million of long-term debt outstanding, which is comprised of two term loans, a finance lease and our Revolving Credit Facility. Of the $74.1 million outstanding, $27.7 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046% over the seven-year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $36.3 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% over the seven-year term, secured in connection with the Lisle, Illinois campus property purchase in February 2022. For each of the term loans, a derivative interest rate swap is in place that fixes the interest rate on 50% of the loan at a market rate at the time the derivative was initiated. Approximately $4.1 million relates to a finance lease for a campus within our Concorde segment. The remaining $6.0 million relates to funds drawn from the $125.0 million Revolving Credit Facility for working capital purposes.
In July 2025, we used cash on hand to repay $6.0 million outstanding on the Revolving Credit Facility. Additionally in July 2025, we issued a letter of credit under the Revolving Credit Facility for $19.6 million, which expires on June 30, 2026, to the ED in order to lift core growth restrictions imposed on Concorde and MIAT campuses as a result of our acquisitions. These two transactions reduced the overall availability under the Revolving Credit Facility to $105.4 million and sub-facility available for letters of credit to $0.4 million.
We are subject to certain customary affirmative and negative covenants under the Revolving Credit Facility and the Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on liens, encumbrances and indebtedness and various financial covenants, including debt service coverage ratios. As of June 30, 2025, we were in compliance with our debt covenants under our Term Loans. Under our Revolving Credit Facility, however, while we were in compliance with the Fixed Charge Coverage and Leverage ratios, our Quick Ratio of 0.62 at June 30, 2025 did not meet the required Quick Ratio of 0.65. The failure of this covenant was primarily due to paying down the Revolving Credit Facility with available cash and additional cash investments in held-to-maturity securities which are excluded from the Quick Ratio calculation. We have obtained a waiver for the failure to meet the quick ratio covenant as of June 30, 2025 from Fifth Third Bank.
See Note 10 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the Revolving Credit Facility.
Dividends
We currently do not pay a cash dividend on our common stock.
Principal Sources of Liquidity
Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans’ benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student’s academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student’s academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through cash payment plans and those under retail installment contracts. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.
Surety Bonds
Each of our campuses must be authorized by the applicable state education agency in which the campus is located to operate and to grant certificates, diplomas or degrees to its students. Our campuses are subject to extensive, ongoing regulation by each of these states. Additionally, our campuses are required to be authorized by the applicable state education agencies of certain other states in which our campuses recruit students. Our insurers issue surety bonds on behalf of our campuses and admissions representatives with multiple states to maintain authorization to conduct our business. We are obligated to reimburse our insurers for any surety bonds that are paid by the insurers. As of June 30, 2025, the total face amount of these surety bonds was approximately $28.3 million.
Operating Activities
Our net cash provided by operating activities was $40.2 million for the nine months ended June 30, 2025, compared to $18.4 million for the nine months ended June 30, 2024.
Net income, after adjustments for non-cash items, for the nine months ended June 30, 2025 provided cash of $109.2 million. The non-cash items included $24.5 million for depreciation and amortization expense, $17.5 million for amortization of right-of-use assets for operating leases, $15.1 million for our provision for credit losses, and $6.4 million for stock-based compensation expense.
Changes in operating assets and liabilities used cash of $69.0 million primarily due to the following:
- The change in deferred revenue used cash of $25.5 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at June 30, 2025 as compared to September 30, 2024.
- The change in receivables used cash of $21.9 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.
- The change in our operating lease liabilities used cash of $16.8 million primarily as a result of rent payments.
- The change in other assets used cash of $5.4 million and was primarily attributable to the increase in notes receivable related to retail installment contracts.
- The change in prepaid expenses and other current assets used cash of $4.5 million primarily due to the timing of payments.
- The change in notes receivable used cash of $4.1 million primarily due to higher utilization of UTI’s proprietary loan program.
- The change in accounts payable and accrued expenses provided cash of $6.5 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.
- The change in income tax payable/receivable provided cash of $3.6 million primarily due to the timing of tax payments.
Net income, after adjustments for non-cash items, for the nine months ended June 30, 2024 provided cash of $70.5 million. The non-cash items included $21.6 million for depreciation and amortization expense, $16.5 million for amortization of right-of-use assets for operating leases, $5.7 million for stock-based compensation expense, and $5.1 million for our provision for credit losses.
Changes in operating assets and liabilities used cash of $52.2 million primarily due to the following:
- The change in deferred revenue used cash of $19.8 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at June 30, 2024 as compared to September 30, 2023.
- Changes in our operating lease liability, primarily as a result of rent payments, used cash of $15.9 million.
- The change in receivables used cash of $9.7 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.
- The increase in prepaid expenses used cash of $7.3 million primarily due to the timing of payments.
- The increase in notes receivable used cash of $4.7 million primarily due to higher utilization of UTI’s proprietary loan program.
- The increase in accounts payable and accrued expenses provided cash of $8.6 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.
Investing Activities
During the nine months ended June 30, 2025, cash used in investing activities was $78.3 million, which included the purchase of held-to-maturity investments of $54.6 million and the purchase of property and equipment of $25.5 million to support new campus and program expansions at both UTI and Concorde.
During the nine months ended June 30, 2024, cash used in investing activities was $16.5 million for the purchase of property and equipment, primarily to support new program expansions at both UTI and Concorde.
Financing Activities
During the nine months ended June 30, 2025, cash used in financing activities was $56.0 million which was primarily related to $50.0 million in net payments on the Revolving Credit Facility. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $4.7 million, and payment of term loans and finance leases of $2.0 million, partially offset by $0.7 million related to proceeds of from stock option exercises.
During the nine months ended June 30, 2024, cash used in financing activities was $39.7 million which was primarily related to $23.0 million in net payments on the Revolving Credit Facility, or $59.0 million in payments offset by $36.0 million in proceeds. Additionally, $11.5 million was used to repurchase Series A Preferred Stock. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details on the repurchase. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $2.2 million, the payment of long-term debt of $1.9 million, and the payment of preferred dividends of $1.1 million.
Seasonality and Trends
Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in the total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.
Critical Accounting Policies and Estimates
The preparation of financial statements and related disclosures in conformity with GAAP and management’s discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the nine months ended June 30, 2025 from those previously disclosed in Part II, Item 7 of our 2024 Annual Report on Form 10-K.
Recent Accounting Pronouncements
For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.
Market risk
As filed, 293 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in our market risk exposure during the nine months ended June 30, 2025. For a discussion of our exposure to market risk, refer to Part II Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in our 2024 Annual Report on Form 10-K.
Controls and procedures
As filed, 3,259 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2025 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.
Risk factors
As filed, 2,148 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item 1A of our 2024 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results. Except as set forth below, there have been no material changes to the risk factors disclosed in Part I, Item 1A of our 2024 Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.
Recent changes by Congress to the laws governing the use of funds received through Title IV Programs could reduce our student population, revenues and/or profit margin.
Congress periodically revises the HEA and other laws, and enacts new laws, governing Title IV Programs and determining the funding level for each Title IV Program. Congress most recently reauthorized the HEA in 2008 and, despite repeated attempts, has not completed a full reauthorization since then. In addition to HEA reauthorization, policies directly related to Title IV Programs and funding for those programs may be impacted by the annual budget and appropriations process as well as by other legislation. In this regard, on July 4, 2025, Congress enacted the One Big Beautiful Bill Act (“OBBBA”). Under the OBBBA, Congress approved amendments to the HEA that, among other things, revised certain Title IV Programs, including provisions that condition the eligibility of educational programs upon compliance with earnings benchmarks that compare former students’ median earnings after completing a program to the median earnings of working adults with lesser credential, and other provisions that will limit or reduce the amount of Title IV Program funding that may be available to some higher education students. The impact of these changes and other changes to the HEA enacted as part of the OBBBA, and of related future regulatory and policy changes, is unknown at this time.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $204.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-10-01 to 2025-06-30 | $613.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months2025-04-01 to 2025-06-30 | $84.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-10-01 to 2025-06-30 | $246.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-04-01 to 2025-06-30 | $14.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-10-01 to 2025-06-30 | $58.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-04-01 to 2025-06-30 | $1.4m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2024-10-01 to 2025-06-30 | $4.7m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $3.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-10-01 to 2025-06-30 | $14.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | $10.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-10-01 to 2025-06-30 | $44.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | $0.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-10-01 to 2025-06-30 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | $0.20 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-10-01 to 2025-06-30 | $0.82 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 55,635,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-10-01 to 2025-06-30 | 55,502,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-10-01 to 2025-06-30 | $40.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-10-01 to 2025-06-30 | $25.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-06-30 | $70.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-30 | $185.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $740.8m | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $185.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-30 | $434.0m | us-gaap:Liabilities |
| Long-term debt | At period end2025-06-30 | $70.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-06-30 | $2.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-06-30 | $306.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001261654-25-000019. Last ingested by Listed: Nov 14, 2026, 12:25 ET. Listed shows no prices and gives no investment advice.